Transdermal Delivery of Sonidegib via Iontophoresis from PEDOT:PSS/Gelatin Hydrogels for Basal Cell Carcinoma Skin Cancer
: In summary, PEDOT:PSS in the BG hydrogel is demonstrated here as a potential drug carrier to improve the Sonidegib release and release-permeation iontophoretically for TDDS.
Authors
- Napa Parinyanitikul (ORCID: https://orcid.org/0000-0003-3701-5663)
- Phimchanok Sakunpongpitiporn
- Anuvat Sirivat (ORCID: https://orcid.org/0000-0002-4798-9325)
- Aumpika Kesornsit
- Sutima Luangdilok (ORCID: https://orcid.org/0000-0003-1415-2331)
- Nattaya Teeyapun (ORCID: https://orcid.org/0009-0006-2650-6247)
- Johannes Schwank
Institutions
- Burapha University (TH)
- Chulalongkorn University (TH)
- University of Michigan (US)
- King Chulalongkorn Memorial Hospital (TH)
Publication Details
- Journal
- Pharmaceutics
- Published
- 2026-04-17
- DOI
- https://doi.org/10.3390/pharmaceutics18040494
- Primary Topic
- Advancements in Transdermal Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Chulalongkorn University
- National Research Council of Thailand